In this issue, we celebrate the UCSF Health Awards winners and get a peek into the 2021-2022 class of proposals for the Catalyst Awards. Best of luck to all!
|
|
Journalist Thuy Vu announces the 2021 UCSF Health Awards winners at UCSFs Mission Bay campus
|
|
UCSF Health Awards Make a Big Splash
at Mission Bay
|
|
The UCSF Health Awards committee is proud to announce the 20 winning companies and Hall of Fame inductees for the 2021 UCSF Health Awards.
“This year's winning class represented the amazing maturity in and acceleration of health innovation. The winning companies represented 1.6% of the companies that applied, and the overall company submissions across the board were so impressive. Hats off to all of the great companies that submitted applications, progressed to the quarterfinals, the final round, and then won at the Grand Finale,” said Mark H. Goldstein, Chairman of the UCSF Health Hub
For more information about the UCSF Health Awards click the link below:
|
|
Health Award for
Best Companies with UCSF DNA
|
|
This award is defined as a company using commercial, in-market digital health technology or solutions that either had been started at UCSF or is deeply influenced by a key leadership role held by UCSF faculty or alumni.
|
|
|
Erica Pollex, Digital and Personalized Health Care, Genentech.
|
Established company with a product in the market:
|
|
|
|
Ken Drazan, Chairman, CEO, & Co-founder, Arsenal Bio.
|
NewCo up and coming company:
|
|
|
|
Health Award for
UCSF Hall of Fame
|
|
This award is given to three ground-breakers in the health tech space with a focus on founders that broke the mold starting a monumental, innovative new company.
|
|
UCSF congratulates the winners and the finalists for their work to advance healthcare and improve patient outcomes through better science and technology.
|
|
Next Up: UCSF Catalyst Awards
|
|
Catalyst Program Director Charles
|
|
Proposals for Catalyst Awards in Review
|
|
The Catalyst Program's dedicated Industry Advisor Selection Committee is busy reviewing the most recent batch of proposals for the 2021-2022 Catalyst Awards. Please connect with Catalyst Program Director, Charles Hart, PhD, if you are interested in reviewing proposals in any of the program's tracks, including Therapeutics, Diagnostics, Medical Devices, Digital Health, and Biotools.
|
|
Genentech Hall at UCSF Mission Bay Campus
|
|
2020-2021 Catalyst Awards Complete
the "Target Product Profile" Step
|
|
In 2019 the Catalyst Program added the creation of a Target Product Profile (“TPP”) to the year's activity cycle to help advance the awarded projects along the translational pathway. This summer 60 interns from UCSF, UC Berkeley, UC Hastings, Stanford, and San Francisco State University helped the 2020-2021 Catalyst Awardee Project Teams create a TPP for their projects. Additionally, both project teams and interns attended workshops on the role of the TPP in translational studies, the importance of the TPP for product development and commercialization, Project Management, Intellectual Property, Innovation & Entrepreneurship, as well as an introduction to company formation. Special thanks to guest lecturers Ken Fang, MD, Erica Pascal, PhD, JD, and James Huie, JD! To conclude this phase of the TPP process, last month project teams presented the TPP and a project update to assembled industry advisors for additional feedback.
|
|
Catalyst Progam Alumni in the News
|
|
Hani Goodarzi Awarded Prestigious Vilcek Prize
|
|
Harrington Innovator-Scholar Award
|
|
Catalyst Awardee Hani Goodarzi, PhD received the Vilcek Prize for Creative Promise in Biomedical Science for using modeling and computational methods to uncover novel molecular players and pathways and therapeutic targets in cancer metastasis and for developing sophisticated molecular tools for the early detection and monitoring of cancer.
|
|
Jennifer Chen, MD and John Chorba, MD, two UCSF Catalyst awardees, won the 2021 Harrington Innovator-Scholar Award for their projects Reversing Liver Fibrosis and A Novel Treatment for Atherosclerosis respectively that also won them their Catalyst Awards. The Harrington Scholar-Innovator Award recognizes physician-scientist innovators throughout the US and Canada, whose research has the potential to change standard of care.
|
|
The Kidney Project Promises to Free Patients from Transplant Waits and Dialysis Machines
|
|
Credit: UCSF
The Kidney Project’s bioartificial kidney, which was successfully implanted in a preclinical model.
|
|
The Kidney Project, a nationwide collaboration led by Catalyst Awardee Shuvo Roy, PhD, took another big step toward becoming reality, earning a $650,000 prize from KidneyX for its first-ever demonstration of a functional prototype of its implantable artificial kidney.
|
|
Catalyst Awardee Ida Sim to Lead Join Program in Computational Precision Health
|
|
Catalyst Awardee Ida Sim, MD, PhD will lead the new groundbreaking joint program between UCSF and UC Berkeley in Computational Precision Health, to be housed at the Bakar Computational Health Sciences Institute at UCSF and the Division of Computing, Data Science, and Society at UC Berkeley. Professor Sim is the director of Digital Health in the Division of General Internal Medicine, and professor of medicine at UCSF. A recognized leader in this field, she is co-founder of Open mHealth and co-founder of Vivli, two not-for-profit entities dedicated to furthering computational precision health.
|
|
Advisor Spotlight: John Jacobsen
|
|
Catalyst Advisor John Jacobsen, PhD, is the Chief Scientific Officer for DICE Therapeutics, a biotech company that designs and develops innovative therapies in immunology for patients with chronic diseases and recently went public. The funds raised in DICE's IPO support the development of oral drugs that could compete against biologic drugs that are injected or infused.
|
|
Join the Innovation Ventures Team!
|
|
The Catalyst Program and Innovation Ventures Philanthropy Fund (InVent Fund) is hiring for a Program Analyst. This exciting role will be involved with cutting-edge translational science projects and help advance projects along the translational pathway to commercialization and patent benefit. Please contact Roopa Ramamoorthi, PhD, PMP, for more details.
|
|
List of Recently Issued UCSF Patents
|
|
|
NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY
METHODS AND SYSTEMS FOR DETECTING BIOLOGICAL COMPONENTS
METHODS OF DIAGNOSING ENDOMETRIOSIS
TRPA1 AND TRPV4 INHIBITORS AND METHODS OF USING THE SAME FOR ORGAN-SPECIFIC INFLAMMATION AND ITCH
DISEASE-ASSOCIATED ANTIGENS AND METHODS OF USE THEREOF
NANOSTRAW DEVICES AND METHODS OF FABRICATING AND USING THE SAME
HIGH DEFINITION MICRODROPLET PRINTER
SYSTEMS AND METHODS FOR MONITORING A PATIENT
THIOSACCHARIDE MUCOLYTIC AGENTS
ENGINEERED ANTIBODIES FOR THE DETECTION OF PHOSPHORYLATED TYROSINE
TARGETED REPLACEMENT OF ENDOGENOUS T CELL RECEPTORS
BIOARTIFICIAL ULTRAFILTRATION DEVICE AND METHODS RELATED THERETO
COMPOSITIONS FOR TREATING INFLAMMATION AND USES THEREOF
ENTERIC CT CONTRAST MATERIAL BASED ON LOW-Z ATOMS
CHIMERIC ANTIGEN RECEPTORS FOR PHAGOCYTOSIS
METHOD FOR FINDING LOW ABUNDANCE SEQUENCES BY HYBRIDIZATION
ENHANCING COGNITION IN THE PRESENCE OF DISTRACTION AND/OR INTERRUPTION
BACK PAIN TREATMENT USING MICROWAVE SOURCES
ANTIBODIES TO COAGULATION FACTOR XIA AND USES THEREOF
PHTHALAZINE DERIVATIVES AS INHIBITORS OF PARP1, PARP2, AND/OR TUBULIN USEFUL FOR THE TREATMENT OF CANCER
REPROGRAMMING OF CELLULAR ADHESION
TARGETED REPLACEMENT OF ENDOGENOUS T CELL RECEPTORS
IN VITRO ASSAYS FOR INHIBITION OF MICROGLIAL ACTIVATION
SYSTEMS AND METHODS USING NUCLEAR MAGNETIC RESONANCE (NMR) TO EVALUATE PAIN AND DEGENERATIVE PROPERTIES OF TISSUE
SEQUENCING OF NUCLEIC ACIDS VIA BARCODING IN DISCRETE ENTITIES
A NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY
SINGLE CELL GENOMIC SEQUENCING USING HYDROGEL BASED DROPLETS
RETINAL CELLSCOPE APPARATUS
SYSTEMS METHODS AND DEVICES FOR CLOSED-LOOP STIMULATION TO
ENHANCE STROKE RECOVERY
|
|
|
UCSF | https://innovation.ucsf.edu
Copyright © 2021 The Regents of the University of California. All Rights Reserved.
|
|
|
|
|
|
|